Replies to post #187107 on Biotech Values

[DewDiligence]

The PFE/HSP deal might end up as a nice fit. Hsp has a horrendous manufacturing history while Pfizer excels in that area.

Moreover, PFE is well positioned to roll out HSP’s product line in emerging markets.